Insider Selling: Plexus Corp. (NASDAQ:PLXS) CEO Sells $234,585.00 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now owns 74,271 shares in the company, valued at $11,615,241.69. This trade represents a 1.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Plexus Trading Up 1.7 %

NASDAQ:PLXS opened at $157.91 on Monday. The company has a market capitalization of $4.28 billion, a P/E ratio of 39.38 and a beta of 0.91. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $170.07. The firm has a fifty day simple moving average of $159.55 and a 200-day simple moving average of $135.65.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.30. The company had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.44 EPS. On average, equities research analysts anticipate that Plexus Corp. will post 6.14 earnings per share for the current year.

Analysts Set New Price Targets

PLXS has been the topic of a number of analyst reports. Benchmark lifted their price objective on shares of Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Monday, October 28th. KeyCorp began coverage on shares of Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Needham & Company LLC increased their price objective on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a report on Friday, October 25th. StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, Stifel Nicolaus increased their price target on Plexus from $136.00 to $150.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $147.25.

Institutional Investors Weigh In On Plexus

A number of large investors have recently bought and sold shares of PLXS. Quarry LP raised its position in Plexus by 573.5% during the 3rd quarter. Quarry LP now owns 229 shares of the technology company’s stock worth $31,000 after buying an additional 195 shares during the last quarter. Quest Partners LLC raised its holdings in shares of Plexus by 36,700.0% during the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after purchasing an additional 367 shares during the last quarter. Point72 DIFC Ltd acquired a new position in Plexus during the third quarter valued at $51,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in Plexus during the third quarter valued at $55,000. Finally, Farther Finance Advisors LLC boosted its holdings in Plexus by 89.4% in the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after purchasing an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.